ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,578Medicare Part D Prescriptions Filled, Including Refills

Rank: 149 out of 670

$532K Total Retail Price of All Prescriptions

Rank: 169 out of 670

301 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 301 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 301 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 7,030 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
HYDROCODONE-ACETAMINOPHEN 439 270 S3 1 1
FUROSEMIDE 382 317 2 6
OMEPRAZOLE 358 293 3 5
LEVOTHYROXINE SODIUM 326 265 4 2
LISINOPRIL 282 181 5 3
WARFARIN SODIUM 255 226 6 13
SIMVASTATIN 239 156 7 4
POTASSIUM CHLORIDE 177 158 8 16
OXYCODONE HCL 174 22 S2 9 72
AMLODIPINE BESYLATE 161 145 10 7
POLYETHYLENE GLYCOL 3350 155 124 11 79
METOPROLOL TARTRATE 144 131 12 9
OXYCODONE HCL-ACETAMINOPHEN 119 69 S2 13 71
METFORMIN HCL 119 85 13 8
DONEPEZIL HCL 115 105 15 31
SERTRALINE HCL 107 88 16 22
NAMENDA 102 100 17 54
GLIPIZIDE 100 73 18 67
ALENDRONATE SODIUM 100 96 18 43
NEXIUM 98 41 20 14
ZOLPIDEM TARTRATE 98 69 20 23
CITALOPRAM HBR 97 67 22 20
CRESTOR 94 78 23 18
GABAPENTIN 90 85 24 11
ISOSORBIDE MONONITRATE ER 85 81 25 45
PHENYTOIN SODIUM EXTENDED 84 64 26 135
PLAVIX 82 74 27 34
PAROXETINE HCL 78 57 28 52
AZITHROMYCIN 75 45 29 35
METOPROLOL SUCCINATE 75 62 29 12
CIPROFLOXACIN HCL 73 50 31 60
CEPHALEXIN 69 55 32 102
MIRTAZAPINE 69 69 32 59
PREDNISONE 66 62 34 40
ATORVASTATIN CALCIUM 64 45 35 15
CLOPIDOGREL 61 50 36 24
TAMSULOSIN HCL 59 44 37 30
HYDROCHLOROTHIAZIDE 58 49 38 10
DEXILANT 57 37 39 70
CLONIDINE HCL 55 47 40 62
NOVOLIN R 54 52 41 176
MORPHINE SULFATE ER 52 13 S2 42 104
PROMETHAZINE HCL 52 13 R 42 106
ETODOLAC 51 39 44 174
PROCRIT 51 51 44 275
DIGOXIN 50 49 46 46
TRAZODONE HCL 50 17 46 39
PROAIR HFA 50 14 46 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.